Factors Associated With Willingness to Receive a COVID-19 Vaccine Among 23,819 Adults Aged 50 Years or Older: An Analysis of the Canadian Longitudinal Study on Aging

Abstract Identifying persons who are least willing to receive a coronavirus disease 2019 (COVID-19) vaccine is critical for increasing uptake via targeted outreach. We conducted a survey of 23,819 Canadian Longitudinal Study on Aging participants from September 29 to December 29, 2020, to assess fac...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of epidemiology Vol. 191; no. 6; pp. 987 - 998
Main Authors Basta, Nicole E, Sohel, Nazmul, Sulis, Giorgia, Wolfson, Christina, Maimon, Geva, Griffith, Lauren E, Kirkland, Susan, McMillan, Jacqueline M, Thompson, Mary, Raina, Parminder
Format Journal Article
LanguageEnglish
Published United States Oxford University Press 20.05.2022
Oxford Publishing Limited (England)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Identifying persons who are least willing to receive a coronavirus disease 2019 (COVID-19) vaccine is critical for increasing uptake via targeted outreach. We conducted a survey of 23,819 Canadian Longitudinal Study on Aging participants from September 29 to December 29, 2020, to assess factors associated with COVID-19 vaccination willingness and reasons for willingness or lack thereof. Among adults aged 50–96 years, 84.1% (95% confidence interval (CI): 83.7, 84.6) were very or somewhat willing to receive a COVID-19 vaccine; 15.9% (95% CI: 15.4, 16.3) were uncertain or very or somewhat unwilling. Based on logistic regression, those who were younger, female, had lower education and income, were non-White, and lived in a rural area were less willing to receive a COVID-19 vaccine. After controlling for these factors, recent receipt of influenza vaccine (adjusted odds ratio = 14.3, 95% CI: 12.5, 16.2) or planning to receive influenza vaccine (adjusted odds ratio = 10.5, 95% CI: 9.5, 11.6), as compared with no receipt or planning, was most strongly associated with COVID-19 vaccination willingness. Willingness was also associated with believing one had never been infected with severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and experiencing negative pandemic consequences. Safety concerns were most common among those unwilling. Our comprehensive assessment of COVID-19 vaccination willingness among older adults in Canada, a prioritized group for vaccination due to their risk of severe COVID-19 outcomes, provides a road map for conducting outreach to increase uptake, which is urgently needed.
AbstractList Identifying persons who are least willing to receive a coronavirus disease 2019 (COVID-19) vaccine is critical for increasing uptake via targeted outreach. We conducted a survey of 23,819 Canadian Longitudinal Study on Aging participants from September 29 to December 29, 2020, to assess factors associated with COVID-19 vaccination willingness and reasons for willingness or lack thereof. Among adults aged 50–96 years, 84.1% (95% confidence interval (CI): 83.7, 84.6) were very or somewhat willing to receive a COVID-19 vaccine; 15.9% (95% CI: 15.4, 16.3) were uncertain or very or somewhat unwilling. Based on logistic regression, those who were younger, female, had lower education and income, were non-White, and lived in a rural area were less willing to receive a COVID-19 vaccine. After controlling for these factors, recent receipt of influenza vaccine (adjusted odds ratio = 14.3, 95% CI: 12.5, 16.2) or planning to receive influenza vaccine (adjusted odds ratio = 10.5, 95% CI: 9.5, 11.6), as compared with no receipt or planning, was most strongly associated with COVID-19 vaccination willingness. Willingness was also associated with believing one had never been infected with severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and experiencing negative pandemic consequences. Safety concerns were most common among those unwilling. Our comprehensive assessment of COVID-19 vaccination willingness among older adults in Canada, a prioritized group for vaccination due to their risk of severe COVID-19 outcomes, provides a road map for conducting outreach to increase uptake, which is urgently needed.
Abstract Identifying persons who are least willing to receive a coronavirus disease 2019 (COVID-19) vaccine is critical for increasing uptake via targeted outreach. We conducted a survey of 23,819 Canadian Longitudinal Study on Aging participants from September 29 to December 29, 2020, to assess factors associated with COVID-19 vaccination willingness and reasons for willingness or lack thereof. Among adults aged 50–96 years, 84.1% (95% confidence interval (CI): 83.7, 84.6) were very or somewhat willing to receive a COVID-19 vaccine; 15.9% (95% CI: 15.4, 16.3) were uncertain or very or somewhat unwilling. Based on logistic regression, those who were younger, female, had lower education and income, were non-White, and lived in a rural area were less willing to receive a COVID-19 vaccine. After controlling for these factors, recent receipt of influenza vaccine (adjusted odds ratio = 14.3, 95% CI: 12.5, 16.2) or planning to receive influenza vaccine (adjusted odds ratio = 10.5, 95% CI: 9.5, 11.6), as compared with no receipt or planning, was most strongly associated with COVID-19 vaccination willingness. Willingness was also associated with believing one had never been infected with severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and experiencing negative pandemic consequences. Safety concerns were most common among those unwilling. Our comprehensive assessment of COVID-19 vaccination willingness among older adults in Canada, a prioritized group for vaccination due to their risk of severe COVID-19 outcomes, provides a road map for conducting outreach to increase uptake, which is urgently needed.
Identifying persons who are least willing to receive a coronavirus disease 2019 (COVID-19) vaccine is critical for increasing uptake via targeted outreach. We conducted a survey of 23,819 Canadian Longitudinal Study on Aging participants from September 29 to December 29, 2020, to assess factors associated with COVID-19 vaccination willingness and reasons for willingness or lack thereof. Among adults aged 50–96 years, 84.1% (95% confidence interval (CI): 83.7, 84.6) were very or somewhat willing to receive a COVID-19 vaccine; 15.9% (95% CI: 15.4, 16.3) were uncertain or very or somewhat unwilling. Based on logistic regression, those who were younger, female, had lower education and income, were non-White, and lived in a rural area were less willing to receive a COVID-19 vaccine. After controlling for these factors, recent receipt of influenza vaccine (adjusted odds ratio = 14.3, 95% CI: 12.5, 16.2) or planning to receive influenza vaccine (adjusted odds ratio = 10.5, 95% CI: 9.5, 11.6), as compared with no receipt or planning, was most strongly associated with COVID-19 vaccination willingness. Willingness was also associated with believing one had never been infected with severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and experiencing negative pandemic consequences. Safety concerns were most common among those unwilling. Our comprehensive assessment of COVID-19 vaccination willingness among older adults in Canada, a prioritized group for vaccination due to their risk of severe COVID-19 outcomes, provides a road map for conducting outreach to increase uptake, which is urgently needed.
Identifying persons who are least willing to receive a coronavirus disease 2019 (COVID-19) vaccine is critical for increasing uptake via targeted outreach. We conducted a survey of 23,819 Canadian Longitudinal Study on Aging participants from September 29 to December 29, 2020, to assess factors associated with COVID-19 vaccination willingness and reasons for willingness or lack thereof. Among adults aged 50-96 years, 84.1% (95% confidence interval (CI): 83.7, 84.6) were very or somewhat willing to receive a COVID-19 vaccine; 15.9% (95% CI: 15.4, 16.3) were uncertain or very or somewhat unwilling. Based on logistic regression, those who were younger, female, had lower education and income, were non-White, and lived in a rural area were less willing to receive a COVID-19 vaccine. After controlling for these factors, recent receipt of influenza vaccine (adjusted odds ratio = 14.3, 95% CI: 12.5, 16.2) or planning to receive influenza vaccine (adjusted odds ratio = 10.5, 95% CI: 9.5, 11.6), as compared with no receipt or planning, was most strongly associated with COVID-19 vaccination willingness. Willingness was also associated with believing one had never been infected with severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and experiencing negative pandemic consequences. Safety concerns were most common among those unwilling. Our comprehensive assessment of COVID-19 vaccination willingness among older adults in Canada, a prioritized group for vaccination due to their risk of severe COVID-19 outcomes, provides a road map for conducting outreach to increase uptake, which is urgently needed.Identifying persons who are least willing to receive a coronavirus disease 2019 (COVID-19) vaccine is critical for increasing uptake via targeted outreach. We conducted a survey of 23,819 Canadian Longitudinal Study on Aging participants from September 29 to December 29, 2020, to assess factors associated with COVID-19 vaccination willingness and reasons for willingness or lack thereof. Among adults aged 50-96 years, 84.1% (95% confidence interval (CI): 83.7, 84.6) were very or somewhat willing to receive a COVID-19 vaccine; 15.9% (95% CI: 15.4, 16.3) were uncertain or very or somewhat unwilling. Based on logistic regression, those who were younger, female, had lower education and income, were non-White, and lived in a rural area were less willing to receive a COVID-19 vaccine. After controlling for these factors, recent receipt of influenza vaccine (adjusted odds ratio = 14.3, 95% CI: 12.5, 16.2) or planning to receive influenza vaccine (adjusted odds ratio = 10.5, 95% CI: 9.5, 11.6), as compared with no receipt or planning, was most strongly associated with COVID-19 vaccination willingness. Willingness was also associated with believing one had never been infected with severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and experiencing negative pandemic consequences. Safety concerns were most common among those unwilling. Our comprehensive assessment of COVID-19 vaccination willingness among older adults in Canada, a prioritized group for vaccination due to their risk of severe COVID-19 outcomes, provides a road map for conducting outreach to increase uptake, which is urgently needed.
Author Thompson, Mary
Kirkland, Susan
Maimon, Geva
Basta, Nicole E
Sulis, Giorgia
McMillan, Jacqueline M
Sohel, Nazmul
Raina, Parminder
Griffith, Lauren E
Wolfson, Christina
Author_xml – sequence: 1
  givenname: Nicole E
  surname: Basta
  fullname: Basta, Nicole E
– sequence: 2
  givenname: Nazmul
  surname: Sohel
  fullname: Sohel, Nazmul
– sequence: 3
  givenname: Giorgia
  surname: Sulis
  fullname: Sulis, Giorgia
– sequence: 4
  givenname: Christina
  surname: Wolfson
  fullname: Wolfson, Christina
– sequence: 5
  givenname: Geva
  surname: Maimon
  fullname: Maimon, Geva
– sequence: 6
  givenname: Lauren E
  surname: Griffith
  fullname: Griffith, Lauren E
– sequence: 7
  givenname: Susan
  surname: Kirkland
  fullname: Kirkland, Susan
– sequence: 8
  givenname: Jacqueline M
  surname: McMillan
  fullname: McMillan, Jacqueline M
– sequence: 9
  givenname: Mary
  surname: Thompson
  fullname: Thompson, Mary
– sequence: 10
  givenname: Parminder
  surname: Raina
  fullname: Raina, Parminder
  email: praina@mcmaster.ca
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35166332$$D View this record in MEDLINE/PubMed
BookMark eNp9kV1rFDEUhoNU7LZ65b0EBBF07Ekymd30Qhi2VgsLC35UvBoyyZnZrLPJOplp2R_k_zRl16JeCCE5nDw8nMN7Qo588EjIUwZvGChxptd49v1WG-DqAZmwfFpkBZfFEZkAAM8UL_gxOYlxDcCYkvCIHAvJikIIPiE_L7UZQh9pGWMwTg9o6Vc3rNLVdc63HmOkQ6Af0aC7QarpfHl9dZExRa-1Mc4jLTfBt5SL17PULO3YDcnWJo8E-g11coeeLjuL_TktfTq620WXug0dVkjn2mvrtKeLpHHDaF0C6KdU7GhIeJumeEweNrqL-OTwnpIvl-8-zz9ki-X7q3m5yEyew5DlLBcmbWmbxlou5cxKVYumlojcCICiFih5zTVYppTIEbBGpUHPJNQNoDglb_fe7Vhv0Br0Q6-7atu7je53VdCu-vvHu1XVhptqpkDkwJPg5UHQhx8jxqHauGiw67THMMYqZaFAKi6nCX3-D7oOY592v6OmcpZLUbBEvdpTpg8x9tjcD8Oguou_SvFXh_gT_ezP-e_Z33kn4MUeCOP2v6ZfHvW6ZQ
CitedBy_id crossref_primary_10_3389_fpubh_2023_1172642
crossref_primary_10_1136_bmjopen_2024_084560
crossref_primary_10_1186_s12879_024_09285_1
crossref_primary_10_2196_37887
crossref_primary_10_1371_journal_pone_0289541
crossref_primary_10_1007_s12062_023_09410_z
crossref_primary_10_1016_j_vaccine_2024_02_045
crossref_primary_10_3390_vaccines10050732
crossref_primary_10_4236_ojim_2023_134036
crossref_primary_10_1016_j_vaccine_2021_11_088
crossref_primary_10_1002_jmv_28738
crossref_primary_10_1016_j_idc_2022_11_002
crossref_primary_10_1002_jmv_28156
crossref_primary_10_3389_fpubh_2022_1051035
crossref_primary_10_3390_vaccines11030542
crossref_primary_10_3390_vaccines10060966
crossref_primary_10_1016_j_pmedr_2023_102548
crossref_primary_10_17269_s41997_023_00746_9
crossref_primary_10_1002_nop2_1954
crossref_primary_10_1111_jep_13764
crossref_primary_10_3390_vaccines10101665
crossref_primary_10_3390_vaccines10040520
Cites_doi 10.1073/pnas.2026322118
10.1017/S071498081500029X
10.1186/s12879-021-06023-9
10.1186/s12889-019-6567-x
10.1016/j.vaccine.2014.01.075
10.1007/s10654-020-00698-1
10.1080/13854046.2016.1254279
10.14745/ccdr.v42i12a02
10.1371/journal.pone.0251963
10.1001/jamahealthforum.2020.1539
10.1038/s41591-020-1124-9
10.1093/ije/dyz173
10.1016/j.vaccine.2018.05.037
10.1016/S0140-6736(21)00306-8
10.1073/pnas.2103700118
ContentType Journal Article
Copyright The Author(s) 2022. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health 2022
The Author(s) 2022. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health.
The Author(s) 2022. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health
Copyright_xml – notice: The Author(s) 2022. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health 2022
– notice: The Author(s) 2022. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health.
– notice: The Author(s) 2022. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health
CorporateAuthor for the Canadian Longitudinal Study on Aging (CLSA) Research Team
CorporateAuthor_xml – name: for the Canadian Longitudinal Study on Aging (CLSA) Research Team
DBID TOX
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QP
7T2
7TK
7U7
7U9
C1K
H94
K9.
NAPCQ
7X8
5PM
DOI 10.1093/aje/kwac029
DatabaseName Open Access: Oxford University Press Open Journals
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Calcium & Calcified Tissue Abstracts
Health and Safety Science Abstracts (Full archive)
Neurosciences Abstracts
Toxicology Abstracts
Virology and AIDS Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Nursing & Allied Health Premium
Virology and AIDS Abstracts
Toxicology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Safety Science Abstracts
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList Nursing & Allied Health Premium
CrossRef

MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: TOX
  name: Oxford University Press Open Access
  url: https://academic.oup.com/journals/
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1476-6256
EndPage 998
ExternalDocumentID 10_1093_aje_kwac029
35166332
10.1093/aje/kwac029
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Canada
GeographicLocations_xml – name: Canada
GrantInformation_xml – fundername: CIHR
GroupedDBID ---
-DZ
-E4
-~X
..I
.2P
.55
.GJ
.I3
.XZ
.ZR
0R~
186
1CY
1TH
23M
2WC
354
3O-
4.4
482
48X
53G
5GY
5RE
5VS
5WA
5WD
6.Y
6J9
70D
85S
8F7
AABZA
AACZT
AAJKP
AAJQQ
AAMVS
AAOGV
AAPGJ
AAPNW
AAPQZ
AAPXW
AAQQT
AARHZ
AASNB
AAUAY
AAUQX
AAVAP
AAWDT
AAWTL
AAYJJ
ABEFU
ABEUO
ABIXL
ABJNI
ABKDP
ABLJU
ABNHQ
ABNKS
ABOCM
ABPTD
ABQLI
ABQTQ
ABSAR
ABSMQ
ABXVV
ABZBJ
ACFRR
ACGFO
ACGFS
ACGOD
ACMRT
ACPQN
ACPRK
ACUFI
ACUTJ
ACUTO
ACZBC
ADBBV
ADEYI
ADEZT
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADQBN
ADRIX
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEJOX
AEKPW
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFNX
AFFZL
AFIYH
AFOFC
AFRAH
AFSHK
AFXEN
AFYAG
AGINJ
AGKEF
AGKRT
AGMDO
AGSYK
AHMBA
AHXPO
AI.
AIAGR
AIJHB
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ALUQC
APIBT
APJGH
APWMN
AQDSO
AQKUS
ASPBG
ATGXG
ATTQO
AVNTJ
AVWKF
AXUDD
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BTRTY
BVRKM
BZKNY
C1A
C45
CAG
CDBKE
COF
CS3
CZ4
DAKXR
DIK
DILTD
D~K
E3Z
EBS
EE~
EIHJH
EJD
EMOBN
F3I
F5P
F9B
FEDTE
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HVGLF
HW0
HZ~
IH2
IOX
J21
KAQDR
KBUDW
KC5
KOP
KQ8
KSI
KSN
L7B
M-Z
M49
MBLQV
ML0
N9A
NEJ
NGC
NOMLY
NOYVH
NTWIH
NU-
NVLIB
O0~
O9-
OAWHX
OCZFY
ODMLO
OHH
OHT
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
O~Y
P2P
P6G
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
QZG
R44
RD5
RHF
RIG
RNI
ROL
ROX
ROZ
RUSNO
RW1
RXO
RZF
RZO
TCURE
TEORI
TJX
TMA
TOX
TR2
UAP
UBC
UHB
UPT
VH1
W8F
WOQ
X7H
X7M
YAYTL
YF5
YKOAZ
YOC
YQI
YROCO
YSK
YXANX
Z0Y
ZGI
ZKX
ZXP
~91
ADMHG
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QP
7T2
7TK
7U7
7U9
C1K
H94
K9.
NAPCQ
7X8
5PM
ID FETCH-LOGICAL-c440t-4143c001dffdd2558d59b3fb5ee2c3006b3e52b2a0d19934e0ebe9a0a850bf0e3
IEDL.DBID TOX
ISSN 0002-9262
1476-6256
IngestDate Tue Sep 17 21:25:37 EDT 2024
Sat Oct 26 04:12:04 EDT 2024
Thu Oct 10 18:43:24 EDT 2024
Thu Sep 12 18:06:01 EDT 2024
Thu Oct 24 09:41:28 EDT 2024
Wed Aug 28 03:16:32 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords COVID-19
Canada
SARS-CoV-2
Canadian Longitudinal Study on Aging
vaccines
coronavirus disease 2019
adults
vaccination
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
The Author(s) 2022. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c440t-4143c001dffdd2558d59b3fb5ee2c3006b3e52b2a0d19934e0ebe9a0a850bf0e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://dx.doi.org/10.1093/aje/kwac029
PMID 35166332
PQID 2675845361
PQPubID 41038
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8903402
proquest_miscellaneous_2629059257
proquest_journals_2675845361
crossref_primary_10_1093_aje_kwac029
pubmed_primary_35166332
oup_primary_10_1093_aje_kwac029
PublicationCentury 2000
PublicationDate 2022-05-20
PublicationDateYYYYMMDD 2022-05-20
PublicationDate_xml – month: 05
  year: 2022
  text: 2022-05-20
  day: 20
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Oxford
PublicationTitle American journal of epidemiology
PublicationTitleAlternate Am J Epidemiol
PublicationYear 2022
Publisher Oxford University Press
Oxford Publishing Limited (England)
Publisher_xml – name: Oxford University Press
– name: Oxford Publishing Limited (England)
References Lazarus (2022060609400315200_ref11) 2021; 27
Canadian Longitudinal Study on Aging (2022060609400315200_ref24)
Goldstein (2022060609400315200_ref4) 2021; 118
World Health Organization (2022060609400315200_ref8)
Malosh (2022060609400315200_ref26) 2014; 32
Ritchie (2022060609400315200_ref5)
Logan (2022060609400315200_ref27) 2018; 36
Kelly (2022060609400315200_ref30) 2021; 21
Sakib (2022060609400315200_ref17) 2019; 19
Castro (2022060609400315200_ref3) 2021; 118
National Advisory Committee on Immunization, Public Health Agency of Canada (2022060609400315200_ref13)
Canadian Longitudinal Study on Aging (2022060609400315200_ref23) 2020
Organisation for Economic Co-operation and Development (2022060609400315200_ref9)
Canadian Longitudinal Study on Aging (2022060609400315200_ref19) 2020
Kirkland (2022060609400315200_ref16) 2015; 34
Dubé (2022060609400315200_ref25) 2016; 42
Wouters (2022060609400315200_ref7) 2021; 397
Levin (2022060609400315200_ref2) 2020; 35
Basta (2022060609400315200_ref1)
Canadian Longitudinal Study on Aging (2022060609400315200_ref21) 2020
Canadian Longitudinal Study on Aging (2022060609400315200_ref20) 2020
Malani (2022060609400315200_ref29) 2020; 1
Frank (2022060609400315200_ref28) 2020
Ritchie (2022060609400315200_ref6)
Nikolovski (2022060609400315200_ref31) 2021; 16
National Advisory Committee on Immunization, Public Health Agency of Canada (2022060609400315200_ref14)
Statistics Canada (2022060609400315200_ref12)
Public Health Agency of Canada (2022060609400315200_ref10) 2020
Raina (2022060609400315200_ref15) 2019; 48
Canadian Longitudinal Study on Aging (2022060609400315200_ref22) 2020
Tuokko (2022060609400315200_ref18) 2017; 31
References_xml – ident: 2022060609400315200_ref14
  contributor:
    fullname: National Advisory Committee on Immunization, Public Health Agency of Canada
– volume-title: COVID-19 Questionnaire (Weekly)
  year: 2020
  ident: 2022060609400315200_ref20
  contributor:
    fullname: Canadian Longitudinal Study on Aging
– volume: 118
  issue: 11
  year: 2021
  ident: 2022060609400315200_ref4
  article-title: Vaccinating the oldest against COVID-19 saves both the most lives and most years of life
  publication-title: Proc Natl Acad Sci U S A.
  doi: 10.1073/pnas.2026322118
  contributor:
    fullname: Goldstein
– volume: 34
  start-page: 366
  issue: 3
  year: 2015
  ident: 2022060609400315200_ref16
  article-title: Mining a unique Canadian resource: the Canadian Longitudinal Study on Aging
  publication-title: Can J Aging.
  doi: 10.1017/S071498081500029X
  contributor:
    fullname: Kirkland
– volume-title: COVID-19 Questionnaire (Baseline)
  year: 2020
  ident: 2022060609400315200_ref19
  contributor:
    fullname: Canadian Longitudinal Study on Aging
– ident: 2022060609400315200_ref1
  contributor:
    fullname: Basta
– volume-title: Seasonal Influenza Vaccination Coverage in Canada, 2019–2020
  year: 2020
  ident: 2022060609400315200_ref10
  contributor:
    fullname: Public Health Agency of Canada
– volume: 21
  start-page: 338
  issue: 1
  year: 2021
  ident: 2022060609400315200_ref30
  article-title: Predictors of willingness to get a COVID-19 vaccine in the U.S.
  publication-title: BMC Infect Dis.
  doi: 10.1186/s12879-021-06023-9
  contributor:
    fullname: Kelly
– volume: 19
  start-page: 243
  issue: 1
  year: 2019
  ident: 2022060609400315200_ref17
  article-title: The prevalence of multimorbidity and associations with lifestyle factors among middle-aged Canadians: an analysis of Canadian Longitudinal Study on Aging data
  publication-title: BMC Public Health.
  doi: 10.1186/s12889-019-6567-x
  contributor:
    fullname: Sakib
– volume: 32
  start-page: 1841
  issue: 16
  year: 2014
  ident: 2022060609400315200_ref26
  article-title: Factors associated with influenza vaccine receipt in community dwelling adults and their children
  publication-title: Vaccine.
  doi: 10.1016/j.vaccine.2014.01.075
  contributor:
    fullname: Malosh
– volume: 35
  start-page: 1123
  issue: 12
  year: 2020
  ident: 2022060609400315200_ref2
  article-title: Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications
  publication-title: Eur J Epidemiol.
  doi: 10.1007/s10654-020-00698-1
  contributor:
    fullname: Levin
– volume: 31
  start-page: 233
  issue: 1
  year: 2017
  ident: 2022060609400315200_ref18
  article-title: Cognitive measures in the Canadian Longitudinal Study on Aging
  publication-title: Clin Neuropsychol.
  doi: 10.1080/13854046.2016.1254279
  contributor:
    fullname: Tuokko
– year: 2020
  ident: 2022060609400315200_ref21
  contributor:
    fullname: Canadian Longitudinal Study on Aging
– volume: 42
  start-page: 246
  issue: 12
  year: 2016
  ident: 2022060609400315200_ref25
  article-title: Vaccine acceptance, hesitancy and refusal in Canada: challenges and potential approaches
  publication-title: Can Commun Dis Rep.
  doi: 10.14745/ccdr.v42i12a02
  contributor:
    fullname: Dubé
– volume: 16
  issue: 5
  year: 2021
  ident: 2022060609400315200_ref31
  article-title: Factors indicating intention to vaccinate with a COVID-19 vaccine among older U.S. adults
  publication-title: PloS One.
  doi: 10.1371/journal.pone.0251963
  contributor:
    fullname: Nikolovski
– ident: 2022060609400315200_ref5
  contributor:
    fullname: Ritchie
– volume: 1
  issue: 12
  year: 2020
  ident: 2022060609400315200_ref29
  article-title: Older adults’ perspectives on a COVID-19 vaccine
  publication-title: JAMA Health Forum.
  doi: 10.1001/jamahealthforum.2020.1539
  contributor:
    fullname: Malani
– ident: 2022060609400315200_ref8
  contributor:
    fullname: World Health Organization
– ident: 2022060609400315200_ref9
  contributor:
    fullname: Organisation for Economic Co-operation and Development
– volume: 27
  start-page: 225
  issue: 2
  year: 2021
  ident: 2022060609400315200_ref11
  article-title: A global survey of potential acceptance of a COVID-19 vaccine
  publication-title: Nat Med.
  doi: 10.1038/s41591-020-1124-9
  contributor:
    fullname: Lazarus
– volume: 48
  start-page: 1752
  issue: 6
  year: 2019
  ident: 2022060609400315200_ref15
  article-title: Cohort profile: the Canadian Longitudinal Study on Aging (CLSA)
  publication-title: Int J Epidemiol.
  doi: 10.1093/ije/dyz173
  contributor:
    fullname: Raina
– volume-title: COVID-19 Questionnaire (Exit)
  year: 2020
  ident: 2022060609400315200_ref23
  contributor:
    fullname: Canadian Longitudinal Study on Aging
– ident: 2022060609400315200_ref6
  contributor:
    fullname: Ritchie
– ident: 2022060609400315200_ref24
  contributor:
    fullname: Canadian Longitudinal Study on Aging
– volume: 36
  start-page: 4118
  issue: 28
  year: 2018
  ident: 2022060609400315200_ref27
  article-title: ‘What have you HEARD about the HERD?’ Does education about local influenza vaccination coverage and herd immunity affect willingness to vaccinate?
  publication-title: Vaccine.
  doi: 10.1016/j.vaccine.2018.05.037
  contributor:
    fullname: Logan
– ident: 2022060609400315200_ref12
  contributor:
    fullname: Statistics Canada
– ident: 2022060609400315200_ref13
  contributor:
    fullname: National Advisory Committee on Immunization, Public Health Agency of Canada
– volume: 397
  start-page: 1023
  issue: 10278
  year: 2021
  ident: 2022060609400315200_ref7
  article-title: Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(21)00306-8
  contributor:
    fullname: Wouters
– year: 2020
  ident: 2022060609400315200_ref22
  contributor:
    fullname: Canadian Longitudinal Study on Aging
– volume: 118
  issue: 15
  year: 2021
  ident: 2022060609400315200_ref3
  article-title: Prioritizing COVID-19 vaccination by age
  publication-title: Proc Natl Acad Sci U S A.
  doi: 10.1073/pnas.2103700118
  contributor:
    fullname: Castro
– volume-title: Canadians’ Willingness to Get a COVID-19 Vaccine: Group Differences and Reasons for Vaccine Hesitancy
  year: 2020
  ident: 2022060609400315200_ref28
  contributor:
    fullname: Frank
SSID ssj0011950
Score 2.546132
Snippet Abstract Identifying persons who are least willing to receive a coronavirus disease 2019 (COVID-19) vaccine is critical for increasing uptake via targeted...
Identifying persons who are least willing to receive a coronavirus disease 2019 (COVID-19) vaccine is critical for increasing uptake via targeted outreach. We...
SourceID pubmedcentral
proquest
crossref
pubmed
oup
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 987
SubjectTerms Adults
Aged
Aging
Canada - epidemiology
Confidence intervals
Coronaviruses
COVID-19 - epidemiology
COVID-19 - prevention & control
COVID-19 Vaccines
Cross-Sectional Studies
Editor's Choice
Female
Humans
Immunization
Influenza
Influenza Vaccines
Longitudinal Studies
Older people
Original Contribution
Pandemics
Public health
Rural areas
SARS-CoV-2
Severe acute respiratory syndrome
Severe acute respiratory syndrome coronavirus 2
Statistical analysis
Vaccination
Vaccines
Viral diseases
Title Factors Associated With Willingness to Receive a COVID-19 Vaccine Among 23,819 Adults Aged 50 Years or Older: An Analysis of the Canadian Longitudinal Study on Aging
URI https://www.ncbi.nlm.nih.gov/pubmed/35166332
https://www.proquest.com/docview/2675845361
https://www.proquest.com/docview/2629059257
https://pubmed.ncbi.nlm.nih.gov/PMC8903402
Volume 191
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1JT9wwFLYQB4RUIbZC2PqQeiTC8TKT9DaCjlg7F5bhFDmOzSYliMkI9Qf1f_a9STJiEGrPfnGivO2z38bYd4s-V0lrQ56rJFQx96Ex3ofOeu4knUjqBNlfnZNrdTbUwyZBdvRJCD-Rh-bJHT6_GcsF1ekhQiH9uxoMp8ECmmTaolxqf9eU4X14dsbxzBSzvcOUH1Mj3_ma_jJbakAi9GqurrA5V6yyhcsmDL7KvtSXbVDXEK2xP_16ag60P9vlcPtYPcDkNqW4J3MGVQmIER1aNzBwNLg5PQ6jBG6MpT2hR0OHQMgD9N3Qo6YcuNs97qM53KE2jKB8hQGN9P4BvQLaXiZQekAICW2TA7goaQDSOKdhW0BJir-hRHIahbTOrvs_r45Owmb-QmiV4lWoEEtZ_L-593mOR48410kmfaadE1aiumbSaZEJw3NKA1SOo0QkhptY84xY_ZXNF2XhNhl0XVfaSLpOxmOlnDIqSrzURmTWqy63AUpNw5z0pW6zkdbhcZkiD9OGhwH7hoz7N8VOy9S00cZRKuhUpLTsRAHbny6jHlFwxBSuHBONSBBqogUL2EYtA9P3SB0hMJMiYN0Z6ZgSUI_u2ZXi8WHSqztOuMQj-tZ_P3ybLQqqrOAaDdcOm69ex24X8U6V7SHSPz3fm8j8X4NY_nI
link.rule.ids 230,315,786,790,891,1611,27946,27947
linkProvider Oxford University Press
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Factors+Associated+With+Willingness+to+Receive+a+COVID-19+Vaccine+Among+23%2C819+Adults+Aged+50+Years+or+Older%3A+An+Analysis+of+the+Canadian+Longitudinal+Study+on+Aging&rft.jtitle=American+journal+of+epidemiology&rft.au=Basta%2C+Nicole+E&rft.au=Sohel%2C+Nazmul&rft.au=Sulis%2C+Giorgia&rft.au=Wolfson%2C+Christina&rft.date=2022-05-20&rft.eissn=1476-6256&rft.volume=191&rft.issue=6&rft.spage=987&rft_id=info:doi/10.1093%2Faje%2Fkwac029&rft_id=info%3Apmid%2F35166332&rft.externalDocID=35166332
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9262&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9262&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9262&client=summon